| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |